Changes in circulating microRNA levels associated with prostate cancer.

We included an individual Taqman qRT–PCR analysis of miR-141 in our experiments in both the initial plasma cohort and the subsequent serum validation cohort, as miR-141 changes in prostate cancer have been reported in the literature, even though the difference in miR-141 quantity did not reach statistical significance in our initial Exiqon qRT–PCR microarray panel screen.

also in 111,027 other papers